Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharmaniaga Bhd's share price for the quarter that ended in Mar. 2024 was RM0.355. Pharmaniaga Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,441 Mil. Therefore, Pharmaniaga Bhd's market cap for the quarter that ended in Mar. 2024 was RM512 Mil.
Pharmaniaga Bhd's quarterly market cap
declined
from Sep. 2023 (RM627 Mil) to Dec. 2023 (RM555 Mil) and
declined
from Dec. 2023 (RM555 Mil) to Mar. 2024 (RM512 Mil).
Pharmaniaga Bhd's annual market cap
declined
from Dec. 2021 (RM969 Mil) to Dec. 2022 (RM714 Mil) and
declined
from Dec. 2022 (RM714 Mil) to Dec. 2023 (RM555 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharmaniaga Bhd's Enterprise Value for Today is RM1,661 Mil.
Pharmaniaga Bhd Market Cap Historical Data
The historical data trend for Pharmaniaga Bhd's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pharmaniaga Bhd's Market Cap
For the Medical Distribution subindustry, Pharmaniaga Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Market Cap distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Market Cap falls into.
Pharmaniaga Bhd Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pharmaniaga Bhd's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pharmaniaga Bhd Market Cap Related Terms
Thank you for viewing the detailed overview of Pharmaniaga Bhd's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia and Other countries, of which key revenue is derived from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:7081 has been successfully added to your 